Published : 29 November, 2024
In an ET Healthworld Webinar, Dr. Vipul Sheth, Senior Consultant at Rajiv Gandhi Cancer Institute & Centre (RGCIRC), shared insights on the transformative potential of CAR-T cell therapy in cancer treatment. While still experimental and associated with certain risks, including mortality in clinical trials, CAR-T therapy is making significant strides, offering hope for previously untreatable cancers. Dr. Sheth emphasized the ongoing advancements in research and technology, which are making CAR-T therapy safer, more accessible, and applicable to a broader range of cancers. With continued innovation, CAR-T therapy is poised to revolutionize oncology, offering new hope to patients globally.
RGCIRC, Niti Bagh
